These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 4359409
1. Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma. Meyer TJ, Ribi EE, Azuma I, Zbar B. J Natl Cancer Inst; 1974 Jan; 52(1):103-11. PubMed ID: 4359409 [No Abstract] [Full Text] [Related]
2. Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3. Azuma I, Ribi EE, Meyer TJ, Zbar B. J Natl Cancer Inst; 1974 Jan; 52(1):95-101. PubMed ID: 4590014 [No Abstract] [Full Text] [Related]
3. Immunotherapy with nonviable microbial components. Ribi E, Milner KC, Granger DL, Kelly MT, Yamamoto K, Brehmer W, Parker R, Smith RF, Strain SM. Ann N Y Acad Sci; 1976 Jan; 277(00):228-38. PubMed ID: 187099 [Abstract] [Full Text] [Related]
4. Immunotherapy of guinea pig cancer with BCG. Zbar B, Rapp HJ. Cancer; 1974 Oct; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315 [No Abstract] [Full Text] [Related]
6. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG. Hanna MG, Snodgrass MJ, Zbar B, Rapp HJ. J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147 [No Abstract] [Full Text] [Related]
11. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG. Harmel RP, Zbar B, Rapp HJ. J Natl Cancer Inst; 1975 Feb; 54(2):515-7. PubMed ID: 234537 [Abstract] [Full Text] [Related]
12. Desensitization of effective anti-turmour immunity in guinea pigs. Wainberg MA, Margolese RG. Eur J Cancer (1965); 1977 Feb; 13(2):131-7. PubMed ID: 192557 [No Abstract] [Full Text] [Related]
13. Intratumor chemoimmunotherapy with mitomycin C and components from mycobacteria in regression of line 10 tumors in guinea pigs. McLaughlin CA, Cantrell JL, Ribi E, Goldberg EP. Cancer Res; 1978 May; 38(5):1311-6. PubMed ID: 205361 [Abstract] [Full Text] [Related]
14. Immunotherapy with tumor cells and BCG in the guinea pig, studied by immunological in vivo and in vitro experiments. Rella W, Chaput B. Oncology; 1978 May; 35(3):136-42. PubMed ID: 209379 [Abstract] [Full Text] [Related]
15. Suppression and immunotherapy of the guinea pig line-10 hepatocarcinoma mediated by nonviable Staphylococcus aureus. Minden P, McClatchy JK, Brunda MJ. J Natl Cancer Inst; 1978 Aug; 61(2):535-8. PubMed ID: 210295 [Abstract] [Full Text] [Related]
16. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment. Boyle MD, Ohanian SH, Borsos T. J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400 [Abstract] [Full Text] [Related]
17. Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties. Lederer E, Adam A, Ciorbaru R, Petit JF, Wietzerbin J. Mol Cell Biochem; 1975 May 30; 7(2):87-104. PubMed ID: 1095912 [No Abstract] [Full Text] [Related]
18. Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs. Meyer TJ, Azuma I, Ribi EE. Immunology; 1975 Feb 30; 28(2):219-29. PubMed ID: 804436 [Abstract] [Full Text] [Related]
19. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets. Zbar B, Rapp HJ, Ribi EE. J Natl Cancer Inst; 1972 Mar 30; 48(3):831-5. PubMed ID: 4333775 [No Abstract] [Full Text] [Related]
20. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG). Hanna MG, Snodgrass MJ, Zbar B, Rapp HJ. Natl Cancer Inst Monogr; 1973 Dec 30; 39():71-85. PubMed ID: 4362524 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]